Health Psychology Section, Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Health Psychology Section, Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Gen Hosp Psychiatry. 2018 Jan-Feb;50:15-19. doi: 10.1016/j.genhosppsych.2017.09.007. Epub 2017 Sep 28.
To validate the factor structure of the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)- which is a composite measure of depression and anxiety using the Patient Health Questionnaire-9 and Generalised Anxiety Disorder Scale (GAD-7), in a sample of haemodialysis patients.
Screening data (n=182) used to select entry into a feasibility study of an online cognitive-behavioural therapy intervention for distress in dialysis patients were analysed here. Structural validity of the PHQ-ADS was evaluated using confirmatory factor analysis (CFA), assessing alternative models including a bi-factor model. In the bi-factor model all items from the PHQ-9 and GAD-7 (16-items in total) were loaded onto a general distress factor. Respective items of the PHQ-9 and GAD-7 were specified as subgroup factors. Omega-hierarchical was calculated to indicate the level of saturation of a multidimensional scale by a general factor. Construct validity was determined against the Brief Illness Perception Questionnaire.
A bi-factor PHQ-ADS model had good fit to the data (chi-square=96.1, p=0.26, CFI=0.99; TLI=0.99; RMSEA=0.02). The general distress factor accounted for approximately 84% of the explained variance (omega-h=0.90). Distress scores were significantly higher in females compare with males. There was a significant association between distress and negative illness perceptions (r=0.58, p<0.01).
The PHQ-ADS appears to have good structural validity in haemodialysis patients and is sufficiently unidimensional to warrant the use of a total distress score. A full psychometric analysis of the PHQ-ADS in a larger sample of dialysis patients is warranted.
使用患者健康问卷-9(PHQ-9)和广泛性焦虑障碍量表(GAD-7),验证用于评估血液透析患者抑郁和焦虑的综合量表——患者健康问卷焦虑和抑郁量表(PHQ-ADS)的因子结构。
对入选透析患者心理困扰的在线认知行为疗法干预可行性研究的筛查数据(n=182)进行分析。使用验证性因子分析(CFA)评估 PHQ-ADS 的结构效度,评估了包括双因素模型在内的替代模型。在双因素模型中,PHQ-9 和 GAD-7 的所有项目(共 16 项)均加载到一般困扰因素上。PHQ-9 和 GAD-7 的各自项目指定为亚组因素。奥米伽-层次被计算以指示一般因素对多维量表的饱和度水平。构念效度是根据简要疾病感知问卷来确定的。
双因素 PHQ-ADS 模型与数据拟合良好(卡方=96.1,p=0.26,CFI=0.99;TLI=0.99;RMSEA=0.02)。一般困扰因素解释了约 84%的方差(奥米伽-h=0.90)。与男性相比,女性的困扰评分明显更高。困扰与负面疾病认知之间存在显著关联(r=0.58,p<0.01)。
PHQ-ADS 在血液透析患者中具有良好的结构效度,且具有足够的单维性,可使用总困扰评分。需要在更大的透析患者样本中对 PHQ-ADS 进行全面的心理测量学分析。